Method for administering insulinotropic peptides

Details Method for administering insulinotropic peptides Method for administering insulinotropic peptides

A - Human Necessities

61

K

A61K 38/16 (2006.01) A61K 38/26 (2006.01)

Patent

CA 2341454

The claimed invention relates to a method of administering glucagon-like peptide-1 molecules by inhalation, a method for treating diabetes by administering glucagon-like peptide-1 molecules by inhalation, and a method for treating hyperglycemia by administering glucagon-like peptide-1 molecules by inhalation.

L'invention concerne un procédé d'administration de molécules du peptide 1 apparentées au glucagon par inhalation, un procédé de traitement du diabète par administration de molécules du peptide 1 apparentées au glucagon par inhalation, et un procédé de traitement de l'hyperglycémie par administration de molécules du peptide 1 apparentées au glucagon par inhalation.

Affiliated with

Also associated with

Rating

Method for administering insulinotropic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for administering insulinotropic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for administering insulinotropic peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1810936